Enquiry/Quote

How to Source Lutetium Lu 177 dotatate for Pharmaceutical Formulation

Lutetium Lu 177 dotatate (Injection, 7.4 GBq/ vial) is classified under Oncology Cancer Care. It is therapeutically aligned with reference brands such as Lutathera (USA, EU). This guide highlights key sourcing factors buyers should consider when procuring high-quality Lutetium Lu 177 dotatate for formulation, R&D, or bulk manufacturing.

Product Overview: Lutathera is a radiolabeled peptide receptor radionuclide therapy (PRRT) used to treat gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that express somatostatin receptors. It works by delivering targeted radiation directly to tumor cells, minimizing damage to surrounding healthy tissue. The therapy is administered via intravenous infusion under specialized medical supervision, usually in cycles of four doses spaced eight weeks apart.

Lutetium Lu 177 dotatate API in Injection form, 7.4 GBq/ vial specification
Lutetium Lu 177 dotatate API – ideal for compliant pharmaceutical formulation.
Quick Insight: Over 60% of formulation delays are linked to poor API sourcing. A well-planned sourcing strategy can reduce risk and accelerate market entry.

1. Regulatory Compliance & Documentation

Ensure suppliers provide:

2. Purity, Grade & Specification Matching

Lutetium Lu 177 dotatate must meet exact grade and purity for your dosage form:

3. Supplier Reliability & Audit History

4. Commercial Terms: Pricing, MOQ & Flexibility

5. Lead Time, Inventory & Logistics

Typical lead time for Lutetium Lu 177 dotatate is 4–6 weeks.

6. Formulation Support

Pro Tip: Engage supplier formulation experts early — it can improve bioavailability and cut development time.

Conclusion

Sourcing Lutetium Lu 177 dotatate is more than procurement—it’s a strategic partnership. With its injection form and 7.4 GBq/ vial specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.

Next Step: Get expert assistance in sourcing Lutetium Lu 177 dotatate.

Request a Quote

Frequently Asked Questions For Sourcing of Lutetium Lu 177 dotatate

What is the typical lead time for Lutetium Lu 177 dotatate?

Lead times range from 4–6 weeks depending on supplier and region.

Is Lutetium Lu 177 dotatate available in multiple grades?

Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.

Does Lutetium Lu 177 dotatate require special storage?

It should be stored in a cool, dry place away from direct sunlight.

Is a Drug Master File (DMF) available for Lutetium Lu 177 dotatate?

Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.

Can I request samples or a pilot batch of Lutetium Lu 177 dotatate?

Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.

What compliance certificates are available for Lutetium Lu 177 dotatate?

Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.

Is Lutetium Lu 177 dotatate suitable for regulated markets like US/EU?

Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.

Can Lutetium Lu 177 dotatate be used in fixed-dose combinations?

Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.